A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors
Clinical trial NCT00397046 · COMPLETED
Trial details
- NCT number
- NCT00397046
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2009-03-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.